SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension.
Phosphodiesterase 5 (PDE5) and soluble guanylate cyclase (sGC) are key regulators of cGMP and pulmonary vascular tone. We sought to determine the impact of mechanical ventilation with O(2) with or without inhaled nitric oxide (iNO) or recombinant human Cu/Zn SOD (rhSOD) on sGC, PDE5, and cGMP in the ovine ductal ligation model of persistent pulmonary hypertension of the newborn (PPHN). PPHN lambs were ventilated with 100% O(2) for 24 h alone or combined with either inhalation of 20 parts per million (ppm) iNO continuously or a single intratracheal dose of rhSOD (5 mg/kg). Ventilated PPHN lambs were compared with PPHN fetuses, control fetuses, and 1-day-old spontaneously breathing lambs (1DSB). In the small pulmonary arteries of 1DSB lambs, sGC expression increased, PDE5 expression decreased, and cGMP concentrations increased relative to fetal levels. In PPHN lambs ventilated with 100% O(2), sGC activity increased to levels comparable with 1DSB levels. However, PDE5 expression and activity increased, and cGMP levels remained at fetal levels. Addition of either iNO or rhSOD decreased PDE5 expression and activity in PPHN lambs and increased cGMP levels to levels comparable with 1DSB lambs. These data suggest that ventilation of PPHN lambs with 100% O(2) impairs cGMP-mediated vasodilation in part due to increased PDE5 expression and activity. The addition of either iNO or rhSOD normalized PDE5 and cGMP levels. Thus therapies designed to decrease PDE5 and increase cGMP, such as iNO and rhSOD, may prove useful in the treatment of PPHN in newborn infants.
Farrow
Kathryn N
KN
Dept. of Pediatrics, Northwestern Univ. Feinberg School of Medicine, 310 E. Superior St., Morton 4-685D, Chicago, IL 60611, USA. k-farrow@northwestern.edu
Lakshminrusimha
Satyan
S
Czech
Lyubov
L
Groh
Beezly S
BS
Gugino
Sylvia F
SF
Davis
Jonathan M
JM
Russell
James A
JA
Steinhorn
Robin H
RH
D000280:Administration, Inhalation; D000818:Animals; D000831:Animals, Newborn; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5 / Q000235:genetics / Q000378:metabolism*; D005260:Female; D006162:Guanylate Cyclase / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D032389:Myocytes, Smooth Muscle / Q000166:cytology / Q000378:metabolism; D009569:Nitric Oxide / Q000008:administration & dosage / Q000378:metabolism; D010547:Persistent Fetal Circulation Syndrome / Q000503:physiopathology*; D011247:Pregnancy; D012756:Sheep; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism*
D009569:Nitric Oxide; D013482:Superoxide Dismutase; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D006162:Guanylate Cyclase
Anal Biochem. 1976 May 7;72:248-54
942051
Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1104-10
9563726
Blood. 2006 Mar 15;107(6):2322-9
16189269
Am J Respir Crit Care Med. 2003 Jun 15;167(12):1600-19
12796054
Pediatrics. 2006 Apr;117(4):1077-83
16585301
Pediatr Res. 1998 Dec;44(6):831-7
9853914
Am J Physiol Lung Cell Mol Physiol. 2008 Dec;295(6):L979-87
18790993
J Pediatr. 1981 Jun;98(6):962-7
7229803
Pediatr Pulmonol. 2001 Feb;31(2):97-105
11180684
Pediatr Res. 1989 Mar;25(3):245-50
2704590
Am J Physiol. 1999 Oct;277(4):L841-7
10516227
Pediatr Res. 2009 Nov;66(5):539-44
19680165
Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L125-30
15447938
Mol Genet Metab. 1998 Nov;65(3):229-37
9851888
J Pediatr. 2009 Dec;155(6):841-847.e1
19836028
J Clin Invest. 2009 Jul;119(7):2009-18
19487814
Anesthesiology. 1999 Jul;91(1):307-10
10422958
N Engl J Med. 1997 Feb 27;336(9):597-604
9036320
Free Radic Biol Med. 2003 Aug 1;35(3):236-56
12885586
Clin Perinatol. 1999 Sep;26(3):601-19
10494467
Am J Respir Crit Care Med. 1999 Sep;160(3):858-65
10471609
Br J Pharmacol. 2008 Nov;155(6):847-56
18660830
Cell Signal. 2001 Oct;13(10):735-41
11602184
Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1812-20
17142346
N Engl J Med. 1997 Feb 27;336(9):605-10
9032045
Am J Physiol. 1997 Mar;272(3 Pt 1):L400-6
9124595
Pediatrics. 2000 Jan;105(1 Pt 1):14-20
10617698
Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L798-806
15964898
Pediatr Res. 1989 Mar;25(3):251-7
2704591
Pediatr Res. 1998 Dec;44(6):821-30
9853913
Circ Res. 2008 Feb 1;102(2):226-33
17991881
Circ Res. 2003 Apr 4;92(6):683-91
12609968
Clin Pharmacol Ther. 2009 Jan;85(1):56-63
18800037
J Clin Invest. 1997 Sep 15;100(6):1448-58
9294110
Am J Respir Crit Care Med. 2006 Dec 15;174(12):1370-7
17008638
Circ Res. 1999 Oct 15;85(8):753-66
10521248
Biochem Biophys Res Commun. 2001 Jan 26;280(3):693-9
11162576
Pediatr Res. 2006 Jan;59(1):137-41
16326983
Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1367-73
15166009
Am J Physiol Lung Cell Mol Physiol. 2005 Oct;289(4):L660-6
15937064
Crit Care Med. 2004 Dec;32(12):2496-501
15599157
Methods. 2001 Dec;25(4):402-8
11846609
Chest. 1988 Mar;93(3 Suppl):133S-138S
3277815
Am J Physiol. 1998 Nov;275(5):L931-41
9815111
N Engl J Med. 2000 Feb 17;342(7):469-74
10675427
Am J Respir Crit Care Med. 1998 Jul;158(1):279-88
9655741
Eur J Biochem. 2003 Mar;270(5):962-70
12603329
Pediatr Res. 2007 Sep;62(3):313-8
17622960
J Clin Invest. 2006 Sep;116(9):2552-61
16955146
Pediatrics. 2001 Apr;107(4):642-7
11335737